儿童重症监护病房实施重症哮喘临床路径
实施后呼吸评分记录和路径依从性接近90%。与基线相比,PICU住院时间从2天降至1天(p=0.0013),总住院时间从4天降至3天(p<0.001),症状缓解时间从66.5小时降至21小时(p=0.036)。提示结构化重症哮喘路径可加速症状缓解并缩短住院时间。
要点
- 实施护士与呼吸治疗师驱动的重症哮喘路径后,PICU住院时间中位数从2天(IQR 1-3)降至1天(IQR 1-2),p=0.0013。
- 总住院时间中位数从4天(IQR 3-6)降至3天(IQR 2-3.75),p<0.001。
- 症状缓解时间中位数从66.5小时降至21小时,p=0.036。
- 呼吸评分记录和路径依从性接近90%,两组入院时疾病严重度和临床基线特征可比。
- 适用人群为24个月至18岁PICU哮喘持续状态患儿,排除严重细菌感染、慢性肺病、心脏病或免疫疾病者。
适用人群与场景
- 24个月至18岁入住PICU的哮喘持续状态患儿。
- 排除严重细菌感染、慢性肺病、心脏病或免疫疾病患者。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 第一步:设计并实施由护士和呼吸治疗师驱动的呼吸评分工具。
- 第二步:执行重症哮喘路径,包含明确的升级/降级治疗指令。
- 原文未提及具体药物剂量、给药途径、频次或目标值。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:横断面研究,基线期后实施重症哮喘路径。
- 人群:24个月至18岁PICU哮喘持续状态患儿,排除严重细菌感染、慢性肺病、心脏病或免疫疾病。
- 干预与对照:实施护士和呼吸治疗师驱动的呼吸评分工具及重症哮喘路径(含升级/降级指令) vs 基线常规管理。
- 主要终点:PICU住院时间中位数从2天(IQR 1-3)降至1天(IQR 1-2),p=0.0013。
- 关键次要终点:总住院时间中位数从4天(IQR 3-6)降至3天(IQR 2-3.75),p<0.001;症状缓解时间中位数从66.5小时降至21小时(依从组),p=0.036。
- 依从性:呼吸评分记录和路径依从性接近90%;两组入院时疾病严重度和临床基线特征可比。
- 不良事件:原文未提及。
证据类型、等级与局限
- 证据类型:单中心横断面研究(基线 vs 实施后)。
- 证据等级或推荐强度:原文未提及。
- 局限:单中心、非随机、样本量较小(n=74和n=78)、实施前后比较设计。
对床旁实践的改变
- 可改变做法:在PICU对严重急性哮喘患儿实施护士和呼吸治疗师驱动的呼吸评分工具及含明确升级/降级指令的临床路径。
- 适用人群:24个月至18岁PICU哮喘持续状态患儿,排除严重细菌感染、慢性肺病、心脏病或免疫疾病者。
- 原文未提及不适用人群的额外信息或常见陷阱。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Acute asthma management has improved significantly across hospitals in the United States due to implementation of standardized care pathways. Management of severe acute asthma in ICUs is less well studied, and variations in management may delay escalation and/or deescalation of therapies and increase length of stay. In order to standardize the management of severe acute asthma in our PICU, a nurse- and respiratory therapist-driven critical care asthma pathway was designed, implemented, and tested.
DESIGN: Cross-sectional study of severe acute asthma at baseline followed by implementation of a critical care asthma pathway.
SETTING: Twenty-six-bed urban quaternary PICU within a children's hospital.
PATIENTS: Patients 24 months to 18 years old admitted to the PICU in status asthmaticus. Patients with severe bacterial infections, chronic lung disease, heart disease, or immune disorders were excluded.
INTERVENTIONS: Implementation of a nurse- and respiratory therapist-driven respiratory scoring tool and critical care asthma pathway with explicit escalation/deescalation instructions.
MEASUREMENTS AND MAIN RESULTS: Primary outcome was PICU length of stay. Secondary outcomes were time to resolution of symptoms and hospital length of stay. Compliance approached 90% for respiratory score documentation and critical care asthma pathway adherence. Severity of illness at admission and clinical baseline characteristics were comparable in both groups. Pre intervention, the median ICU length of stay was 2 days (interquartile range, 1-3 d) with an overall hospital length of stay of 4 days (interquartile range, 3-6 d) (n = 74). After implementation of the critical care asthma pathway, the ICU length of stay was 1 day (interquartile range, 1-2 d) (p = 0.0013; n = 78) with an overall length of stay of 3 days (interquartile range, 2-3.75 d) (p < 0.001). The time to resolution of symptoms was reduced from a median of 66.5 hours in the preintervention group to 21 hours in the postintervention compliant group (p = 0.036).
CONCLUSIONS: The use of a structured critical care asthma pathway, driven by an ICU nurse and respiratory therapist, is associated with faster resolution of symptoms, decreased ICU, and overall hospital lengths of stay in children admitted to an ICU for severe acute asthma.
参考来源
- Miksa M, Kaushik S, Antovert G, et al. Implementation of a Critical Care Asthma Pathway in the PICU. Crit Care Explor. 2021. PMID: 33604577. doi:10.1097/CCE.0000000000000334
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。